Svar på skriftligt spörsmål om begränsningen av den expedierade mängden av dyra läkemedel med specialersättning

This procedure is a response to a written question concerning the limitation of the expedited quantity of expensive medicines with special reimbursement. It addresses the supply and cost of certain high-value pharmaceuticals. The question and its answer likely affect patients requiring specialized medication, healthcare providers, and pharmaceutical companies, potentially impacting drug pricing and availability.